Exchange: OTC·Updated 02:11 PM EDT

VCNX Vaccinex Inc

$1.14
$0.01
(0.87%)
Today
Mkt Cap$3.04M
Vol803.00

About VCNX

Vaccinex, Inc. operates as a clinical-stage biotechnology company. It engages in the development of targeted bio therapeutics to treat serious diseases and conditions with unmet medical needs, including cancer, neurodegenerative diseases, and autoimmune disorders. The firm focuses on the development of Pepinemab for the treatment of non-small cell lung cancer, or NSCLC, osteosarcoma, melanoma, and Huntington’s disease. Its product pipeline includes the SEMA4D antibody platform and ActivMAb antibody discovery platform. The company was founded by Maurice Zauderer in1997 and is headquartered in Rochester, NY.
52

Neutral Sentiment

How do you feel about VCNX?

Javivi33
$VCNX It looks like that with the lastt publication in Nature, in spite I've tried to filter again the hype..GPT insist that it changes the paradigm with the pharma. Please filter it also to check what is going on.
3
Javivi33
$VCNX I am starting to think that Friedberg wants the glory of fixing the Alzheimer himself..83 years old..if he does..we are rich, but it is going to take time. Next phase is critical.
2
Tyjelly
$VCNX if anyone’s board and wants to deep dive. Read up on friedberg and Arizona Star Resources.
1
Javivi33
$VCNX They are recruiting to start on January 2027...in my opinion in February they'll already have data enough to see big movements in the price. If not..probably will be a "Good bye folks". I have faith in pepinemab, Friedberg also...60 million xtra. Faith!

Advertisement|Remove ads.